Jie Qian Selected Research

Phosphopeptides

9/2013	MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.
7/2009	Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Qian Research Topics

Disease

24	Neoplasms (Cancer) 01/2023 - 05/2004
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 01/2018
15	Myocardial Infarction 03/2024 - 03/2012
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 04/2002
10	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 03/2010
9	Thrombosis (Thrombus) 11/2023 - 04/2007
8	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2009
8	Inflammation (Inflammations) 01/2023 - 01/2008
7	Coronary Artery Disease (Coronary Atherosclerosis) 02/2024 - 03/2010
7	Lung Neoplasms (Lung Cancer) 07/2022 - 11/2018
7	Adenocarcinoma of Lung 06/2022 - 01/2018
6	Heart Arrest (Cardiac Arrest) 04/2016 - 06/2014
6	Ventricular Fibrillation 04/2016 - 06/2014
5	Rheumatoid Arthritis 01/2023 - 01/2008
4	Stroke (Strokes) 05/2024 - 12/2015
4	Diabetes Mellitus 10/2023 - 10/2013
4	Death (Near-Death Experience) 04/2023 - 03/2012
4	Melanoma (Melanoma, Malignant) 01/2023 - 07/2009
4	Hyperplasia 11/2022 - 11/2007
4	Ischemia 01/2022 - 03/2012
4	Lupus Nephritis 01/2019 - 04/2005
3	Hypertension (High Blood Pressure) 12/2023 - 10/2013
3	Acute Coronary Syndrome 11/2023 - 03/2008
3	Neointima 11/2023 - 03/2012
3	Experimental Melanoma 01/2023 - 09/2011
3	ST Elevation Myocardial Infarction 01/2020 - 10/2013
2	Hyperglycemia 03/2024 - 10/2022
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2024 - 01/2023
2	Pathologic Constriction (Stenosis) 04/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2023
2	Infections 01/2023 - 09/2016
2	Heart Failure 07/2022 - 04/2021
2	Atherosclerosis 11/2021 - 01/2006
2	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 12/2018
2	COVID-19 01/2021 - 01/2020
2	Genomic Instability 06/2019 - 01/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 03/2010
2	Experimental Arthritis 01/2018 - 01/2008
2	Hepatitis 12/2014 - 01/2013
2	Leukemia 09/2013 - 05/2007
2	Carcinogenesis 08/2012 - 10/2006

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2003
8	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2018
7	CytokinesIBA 01/2023 - 11/2012
7	VaccinesIBA 01/2023 - 09/2011
6	LipidsIBA 11/2023 - 03/2012
6	omega-Chloroacetophenone (Mace)IBA 07/2023 - 03/2012
6	AntigensIBA 01/2023 - 07/2004
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 05/2021
4	oxidized low density lipoproteinIBA 03/2024 - 01/2022
4	LDL CholesterolIBA 01/2023 - 01/2016
4	anlotinibIBA 07/2022 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2020 - 02/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2014
4	InterferonsIBA 12/2018 - 05/2003
3	Lipoprotein(a)IBA 05/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	Sirolimus (Rapamycin)FDA Link 01/2022 - 03/2012
3	AdiponectinIBA 01/2020 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 05/2024 - 01/2016
2	lipoprotein cholesterolIBA 05/2024 - 01/2022
2	CholesterolIBA 05/2024 - 01/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 01/2022
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2021
2	Interleukin-12 (IL 12)IBA 01/2023 - 01/2020
2	empagliflozinIBA 10/2022 - 01/2022
2	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 11/2004
2	MetalsIBA 01/2021 - 02/2012
2	B7-H1 AntigenIBA 07/2020 - 01/2020
2	atezolizumabIBA 01/2020 - 01/2020
2	AutoantibodiesIBA 01/2020 - 10/2017
2	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 05/2015
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 12/2019
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2019 - 10/2006
2	Interferon Type IIBA 01/2019 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 04/2014
2	OsteopontinIBA 01/2018 - 01/2018
2	EnzymesIBA 01/2018 - 09/2013
2	Oxygen (Dioxygen)IBA 12/2015 - 12/2015
2	InterleukinsIBA 08/2014 - 04/2013
2	PolymersIBA 02/2014 - 03/2012
2	PhosphopeptidesIBA 09/2013 - 07/2009
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2013 - 11/2012

Therapy/Procedure

12	Therapeutics 01/2024 - 08/2012
11	Stents 11/2023 - 11/2007
8	Immunotherapy 07/2022 - 07/2009
7	Percutaneous Coronary Intervention 11/2023 - 03/2010
6	Resuscitation 04/2016 - 06/2014
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2018
5	Cardiopulmonary Resuscitation (CPR) 04/2016 - 06/2014
4	Adjuvant Chemotherapy 01/2022 - 11/2018
4	Drug-Eluting Stents 01/2021 - 03/2012
2	Glycemic Control 10/2023 - 01/2021
2	Radiotherapy 01/2022 - 11/2012
2	Catheters 01/2021 - 01/2021
2	Transplantation 01/2020 - 12/2019
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2019 - 01/2019